Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rapid Commun Mass Spectrom ; 15(1): 41-9, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11135423

RESUMO

Epothilone B is a 16-membered macrolide produced by the myxobacterium Sorangium cellulosum and is currently under clinical investigation. Experimentally, epothilone B demonstrates potent antiproliferative activity at the nanomolar level in vitro, and potent regression-producing antitumor activity in vivo, similar to paclitaxel (Taxol). In order to foster the design of improved derivatives, the potential biotransformation products of epothilone B formed in liver of tumor-bearing mice after intravenous administration of 10 mg/kg were characterized in an early stage of compound development. Solely on the basis of capillary high-performance liquid chromatography, combined either with electrospray tandem mass spectrometry (in precursor and product ion scan mode) and single analyzing time-of-flight mass spectrometry (H/D exchange and accurate mass measurement), three main metabolites could be detected. The three metabolites, formed by the liver, have in common that the epoxide ring was hydrolyzed and that the macrocyclic lactone ring was opened to the acid. In two cases it is assumed that open-chain intermediates re-cycled either to a lactone or, after conjugation with taurine, to the respective lactam. The proposed structures were additionally supported by the determination of the number of the exchangeable hydrogen atoms and by confirmation of the proposed elemental composition by exact mass measurement.


Assuntos
Antineoplásicos/metabolismo , Cromatografia Líquida de Alta Pressão/métodos , Epotilonas , Compostos de Epóxi/metabolismo , Espectrometria de Massas/métodos , Neoplasias Experimentais/metabolismo , Tiazóis/metabolismo , Animais , Antineoplásicos/química , Antineoplásicos/farmacocinética , Biotransformação , Compostos de Epóxi/química , Compostos de Epóxi/farmacocinética , Feminino , Humanos , Fígado/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Tiazóis/química , Tiazóis/farmacocinética
2.
J Chromatogr B Biomed Sci Appl ; 748(2): 349-59, 2000 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-11087077

RESUMO

An assay, based on pre-column derivatization and micro-high-performance liquid chromatography-tandem mass spectrometry, was developed for the determination of the GABA(B) agonist CGP 44532 in rat plasma. CGP 44532, a highly polar 3-amino-2(S)-hydroxypropylmethylphosphinic acid, presented difficulties in developing a chromatographic method for the analysis of the compound in rat plasma. Instead of analyzing the target compound directly, it was derivatized prior to separation to a 4-nitrobenzylcarbamate isopropyliden derivative. In order to reach the required quantitation limit, on-line solid-phase extraction was utilized for sample clean-up and reversed-phase micro-column high-performance liquid chromatography, for separation of the plasma samples. The separated compounds were detected by negative electrospray tandem mass spectrometry in selected reaction monitoring mode. The derivatives show good chromatographic and mass spectrometric properties and both the target compound and the internal standard, could be eluted as symmetrical peaks with good signal/noise ratio. The MS-MS detection was selective and sensitive due to the straight fragmentation pattern. After injection of 200-microl sample aliquots, the limit of quantification was 10 ng ml(-1). The analytical assay is usable in the range of 10-500 ng ml(-1).


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Organofosfonatos/sangue , Espectrometria de Massas por Ionização por Electrospray/métodos , Ácido gama-Aminobutírico/análogos & derivados , Ácido gama-Aminobutírico/sangue , Animais , Organofosfonatos/farmacocinética , Ácidos Fosfínicos , Ratos , Padrões de Referência , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Ácido gama-Aminobutírico/farmacocinética
3.
J Chromatogr B Biomed Sci Appl ; 720(1-2): 171-8, 1998 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-9892079

RESUMO

This report describes a specific and highly sensitive gas chromatography-mass spectrometry (GC-MS) assay for the analysis of industrially produced 2-hydroxypropyl-gamma-cyclodextrin, a heterogeneous mixture of homologues and isomers, in plasma of cynomolgus monkeys. Instead of analyzing the polysaccharide mixture as a whole, in a first step the HP-gamma-cyclodextrin mixture, together with the internal standard (2,6-di-O-methyl-beta-cyclodextrin), was deuteromethylated, and in a second step hydrolyzed with hydrochloric acid to the respective monosaccharides. The resulting reaction mixture was trimethylsilylated to 1,4-bis(O-trimethylsilyl)-2,3-bis-O-deuteromethyl-6-O-2'-deuter omethoxypropylglucose (representative for HP-gamma-CD) and 1,4-bis-(O-trimethylsilyl)-bis-2,6-O-methyl-3-O-deuteromethylglucose+ ++ (representative for the internal standard), respectively, and analyzed by GC-MS. The limit of quantification of this assay was 20 nmol/l.


Assuntos
Ciclodextrinas/sangue , Cromatografia Gasosa-Espectrometria de Massas/métodos , beta-Ciclodextrinas , gama-Ciclodextrinas , 2-Hidroxipropil-beta-Ciclodextrina , Administração Oral , Animais , Calibragem , Ciclodextrinas/administração & dosagem , Macaca fascicularis , Padrões de Referência , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...